Elevated plasma levels of immunoreactive urotensin II and its increased urinary excretion in patients with Type 2 diabetes mellitus: association with progress of diabetic nephropathy
- 1 October 2004
- Vol. 25 (10) , 1809-1814
- https://doi.org/10.1016/j.peptides.2004.06.024
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 24 references indexed in Scilit:
- Translational Medicine in Fish-derived Peptides: From Fish Endocrinology to Human Physiology and DiseasesEndocrine Journal, 2004
- Role of urotensin II gene in genetic susceptibility to Type 2 diabetes mellitus in Japanese subjectsDiabetologia, 2003
- Increased plasma urotensin II levels in patients with diabetes mellitusClinical Science, 2003
- Role of urotensin II in patients on dialysisThe Lancet, 2001
- Inhibition of Insulin Release by Urotensin II - A Study on the Perfused Rat PancreasHormone and Metabolic Research, 2001
- Cardiostimulant effects of urotensin‐II in human heart in vitroBritish Journal of Pharmacology, 2001
- Differential vasoconstrictor activity of human urotensin‐II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkeyBritish Journal of Pharmacology, 2000
- Human urotensin‐II is an endothelium‐dependent vasodilator in rat small arteriesBritish Journal of Pharmacology, 2000
- Elevated Plasma Immunoreactive Neuropeptide Y Concentrations and Its Increased Urinary Excretion in Patients with Advanced Diabetic Nephropathy.Endocrine Journal, 1999
- Urinary immunoreactive brain natriuretic peptide in patients with renal diseaseRegulatory Peptides, 1996